Industry Reports
Mundipharma and CellAct announce new deal for the worldwide development and commercialization of smart chemotherapy CAP7.1
The Mundipharma network of independent associated companies announced that it has acquired from CellAct the worldwide development, commercialization and manufacturing rights to CAP7.1. ...
Industry Reports
IFM Therapeutics To Be Acquired by Bristol- Myers Squibb To Strengthen Oncology Pipeline Focus On Innate Immunity
Bristol-Myers Squibb Company and IFM Therapeutics announced that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire all of the...
Press Releases
The Great Hall of China: double digit growth at CPhI China
P-MEC China, CPHI china , UBM Sinoexpo,CCCMHPIE,Chinese pharmaceutical market development,Asia’s largest pharma event CPhI and P-MEC China, organised by UBM EMEA, UBM Sinoexpo and China...
Clinical Trials
BioSight Completed Patient Enrollment and Treatment in its Extended Acute Leukemia Phase I/II Clinical Trial
BioSight, Ltd, a pharmaceutical development company, focused on the development of targeted oncology therapeutics with reduced toxicity, announced completion of last patient treatment in...
Industry Reports
TraceLink Breaks New Record for Highest Quarterly Sales Bookings in Q2 2017
TraceLink Inc., the World’s Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better patient...
News
selvita and the leukemia & lymphoma society announce partnership to advance sel120 into phase i for aml patients
Selvita S.A. and The Leukemia & Lymphoma Society (LLS) announced a partnership to co-fund further preclinical and clinical development of a targeted therapy to...
Articles
Cancer drug screening process saves discovery time and limits use of mice
A method of testing drugs thatprompt the immune system to attack and destroy cancer cells has been developed which can speed up drug discovering...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read